Literature DB >> 3225761

Improved delivery through biological membranes. XXXL: Solubilization and stabilization of an estradiol chemical delivery system by modified beta-cyclodextrins.

M E Brewster1, K S Estes, T Loftsson, R Perchalski, H Derendorf, G Mullersman, N Bodor.   

Abstract

A dihydropyridine in equilibrium pyridinium salt chemical delivery system (CDS) for estradiol (E2CDS) was complexed with various modified beta-cyclodextrins including hydroxyethyl-beta-cyclodextrin (HECD), hydroxypropyl-beta-cyclodextrin (HPCD), and heptakis(2,6-di-O-methyl)-beta-cyclodextrin (DMCD). Complex formation with all of these cyclodextrins resulted in dramatic increases in the water solubility of E2CDS. Studies on the complex of E2CDS and HPCD (E2CDS-CD) indicated that the encapsulated estrogen was approximately four times more stable than the unmanipulated CDS, producing an estimated half-life of degradation of 4 years compared with 1.2 years for the uncomplexed drug at room temperature. The complexation of E2CDS and HPCD also stabilized the dihydronicotinate in solutions containing potassium ferricyanide. This formulation was shown to be equivalent to E2CDS in dimethyl sulfoxide in delivering the oxidized, estradiol precursor (E2Q+) to the brain, and also produced similar biological responses; these included decreased luteinizing hormone (LH) secretion and a decrease in the rate of weight gain in castrated female rats.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3225761     DOI: 10.1002/jps.2600771118

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  A redox-based system that enhances delivery of estradiol to the brain: pharmacokinetic evaluation in the dog.

Authors:  K Dietzel; V Keuth; K S Estes; M E Brewster; R M Clemmons; R Vistelle; N S Bodor; H Derendorf
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

Review 2.  Testosterone therapy in men: clinical and pharmacological perspectives.

Authors:  A Gambineri; R Pasquali
Journal:  J Endocrinol Invest       Date:  2000-03       Impact factor: 4.256

3.  The effects of cyclodextrins on the disposition of intravenously injected drugs in the rat.

Authors:  H W Frijlink; E J Franssen; A C Eissens; R Oosting; C F Lerk; D K Meijer
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

4.  "All in the mind"? Brain-targeting chemical delivery system of 17β-estradiol (Estredox) produces significant uterotrophic side effect.

Authors:  Katalin Prokai-Tatrai; Szabolcs Szarka; Vien Nguyen; Fatima Sahyouni; Cary Walker; Shastazia White; Tatjana Talamantes; Laszlo Prokai
Journal:  Pharm Anal Acta       Date:  2012

5.  The pharmacokinetics of beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin in the rat.

Authors:  H W Frijlink; J Visser; N R Hefting; R Oosting; D K Meijer; C F Lerk
Journal:  Pharm Res       Date:  1990-12       Impact factor: 4.200

6.  Evaluation of a brain-targeting zidovudine chemical delivery system in dogs.

Authors:  M E Brewster; W R Anderson; A I Webb; L M Pablo; D Meinsma; D Moreno; H Derendorf; N Bodor; E Pop
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

7.  A redox-based chemical delivery system that enhances estradiol distribution to the brain: disposition studies in the rat.

Authors:  K S Estes; V Keuth; K Dietzel; M E Brewster; N S Bodor; H Derendorf
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.